Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme (ATTAC-II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02465268
Recruitment Status : Recruiting
First Posted : June 8, 2015
Last Update Posted : January 11, 2022
University of Florida
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Immunomic Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2023
Estimated Study Completion Date : June 2024